Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
2MB
[thumbnail of Supporting Information]
Preview
PDF (Supporting Information) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB

Item Type:Article
Title:Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC
Creators Name:Messerschmidt, C., Obermayer, B., Klinghammer, K., Ochsenreither, S., Treue, D., Stenzinger, A., Glimm, H., Fröhling, S., Kindler, T., Brandts, C.H., Schulze-Osthoff, K., Weichert, W., Tinhofer, I., Klauschen, F., Keilholz, U., Beule, D. and Rieke, D.T.
Abstract:Immune checkpoint inhibition leads to response in some patients with head and neck squamous cell carcinoma (HNSCC). Robust biomarkers are lacking to date. We analyzed viral status, gene expression signatures, mutational load and mutational signatures in whole exome and RNA-sequencing data of the HNSCC TCGA dataset (N = 496) and a validation set (DKTK MASTER cohort, N = 10). Public single-cell gene expression data from 17 HPV-negative HNSCC were separately re-analyzed. APOBEC3-associated TCW motif mutations but not total single nucleotide variant burden were significantly associated with inflammation. This association was restricted to HPV-negative HNSCC samples. An APOBEC-enriched, HPV-negative subgroup was identified, that showed higher T-cell inflammation and immune checkpoint expression, as well as expression of APOBEC3 genes. Mutations in immune-evasion pathways were also enriched in these tumors. Analysis of single-cell sequencing data identified expression of APOBEC3B and 3C genes in malignant cells. We identified an APOBEC-enriched subgroup of HPV-negative HNSCC with a distinct immunogenic phenotype, potentially mediating response to immunotherapy.
Keywords:Immune Checkpoint Inhibition, Head and Neck Cancer, APOBEC, Mutational Signature, Tumor Inflammation
Source:International Journal of Cancer
ISSN:0020-7136
Publisher:Wiley
Volume:147
Number:8
Page Range:2293-2302
Date:15 October 2020
Official Publication:https://doi.org/10.1002/ijc.33123
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library